Three Studies Show Less Intensive Cancer Treatments Can Lead to Better Outcomes and Fewer Complications

Chicago, Illinois United States of America
A German study comparing chemotherapy and surgery versus chemotherapy, surgery, and radiation for esophageal cancer found those who received only chemotherapy and surgery had a higher survival rate after three years.
In a study on ovarian cancer, avoiding lymph node removal during surgery had no difference in overall survival after nine years and fewer complications.
Researchers compared two chemotherapy regimens for advanced Hodgkin lymphoma and found the less intensive treatment was more effective in keeping the disease in check for four years and caused fewer side effects.
Three studies presented at the American Society of Clinical Oncology conference suggest less intensive cancer treatments can lead to better outcomes and fewer complications.
Three Studies Show Less Intensive Cancer Treatments Can Lead to Better Outcomes and Fewer Complications

Cancer patients often experience improved outcomes and a better quality of life with less intensive treatment, according to recent research presented at the world's largest cancer conference. In three separate studies involving ovarian, esophageal, and Hodgkin lymphoma, researchers found that scaling back treatment can be just as effective as more aggressive approaches while causing fewer complications.

Firstly, French researchers reported that avoiding lymph node removal during surgery for advanced ovarian cancer is safe and does not compromise survival. In a study of 379 patients, those who underwent less-extensive surgery had no difference in overall survival after nine years and fewer complications such as the need for blood transfusions.

Secondly, a German study compared two treatment plans for esophageal cancer: chemotherapy and surgery versus chemotherapy, surgery, and radiation. The results showed that those who received only chemotherapy and surgery had a higher survival rate (57% vs. 51%) after three years.

Lastly, researchers compared two chemotherapy regimens for advanced Hodgkin lymphoma and found that the less intensive treatment was more effective in keeping the disease in check (94% vs. 91%) for four years and caused fewer side effects.

These findings are part of a larger trend towards optimizing cancer care by questioning whether all the treatment used in the past is necessary. Thirty years ago, cancer research focused on doing more, but now researchers are asking if less can lead to better outcomes for patients. Dr. Tatjana Kolevska, medical director for the Kaiser Permanente National Cancer Excellence Program, emphasized that this question should be asked frequently.

The good news is that cancer treatment is becoming more effective and easier to tolerate with fewer short-term and long-term complications. Dr. William G. Nelson of Johns Hopkins School of Medicine also noted the importance of less intensive treatments in cancer care.

These studies were presented at an American Society of Clinical Oncology conference in Chicago.


Article Image
Article Image
Article Image
Article Image
Article Image
Article Image

Confidence

100%

No Doubts Found At Time Of Publication

Sources

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
(Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

Cancer patients often do better with less intensive treatment, new research finds

KSL News Monday, 03 June 2024 09:52
  • Unique Points
    • Doctors reported that scaling back treatment for three types of cancer can make life easier for patients without compromising outcomes at the world’s largest cancer conference.
    • French researchers found it is safe to avoid removing lymph nodes during surgery for advanced ovarian cancer in half of the patients, resulting in fewer complications after nine years.
    • A comparison of two chemotherapy regimens for advanced Hodgkin lymphoma found the less intensive treatment was more effective and caused fewer side effects, keeping the disease in check in 94% of people after four years.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (0%)
    None Found At Time Of Publication

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
(Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

Cancer patients often do better with less intensive treatment, new research finds

The Associated Press News Site (USA) Sunday, 02 June 2024 12:01
  • Unique Points
    • French researchers found that it's safe to avoid removing lymph nodes during surgery for advanced ovarian cancer in half of the patients, as there was no difference in survival after nine years and fewer complications.
    • German study showed that out of 438 people with esophageal cancer treated with either chemotherapy and surgery or chemotherapy, surgery and radiation, those who received only chemotherapy and surgery had a higher survival rate (57% vs. 51%) after three years.
    • A comparison of two chemotherapy regimens for advanced Hodgkin lymphoma found that the less intensive treatment was more effective in keeping the disease in check (94% vs. 91%) for four years and caused fewer side effects.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (100%)
    None Found At Time Of Publication
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (0%)
    None Found At Time Of Publication

99%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermine the credibility of the source. It is calculated as:
(Site Conflicts Of Interest + Author Conflicts Of Interest) / 2.0 * 0.2 + ArticleBiasScore * 0.20 + UniquePointsScore * 0.05 + DeceptionScore * 0.20 + ReadabilityScore * 0.05 + FallacyScore * 0.20

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

Cancer patients often do better with less intensive treatment, new research finds

The Boston Globe Sunday, 02 June 2024 00:00
  • Unique Points
    • Doctors reported that scaling back treatment for three types of cancer can make life easier for patients without compromising outcomes at the world’s largest cancer conference.
    • French researchers found it is safe to avoid removing lymph nodes during surgery for advanced ovarian cancer in half of the patients, as there was no difference in survival after nine years and fewer complications.
    • A comparison of two chemotherapy regimens for advanced Hodgkin lymphoma found that the less intensive treatment was more effective in keeping the disease in check (94% vs. 91%) for four years and caused fewer side effects.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (100%)
    None Found At Time Of Publication
  • Fallacies (95%)
    No formal fallacies found. Some informal fallacies: Dichotomous depiction and appeal to authority. The article presents a dichotomous view of treatment options (more vs less intensive) without considering the nuances or other possible combinations of treatments. It also relies on an appeal to authority by quoting experts' opinions, such as Dr. Tatjana Kolevska and Dr. William G. Nelson.
    • French researchers found that it’s safe to avoid removing lymph nodes that appear healthy during surgery for advanced ovarian cancer.
    • A comparison of two chemotherapy regimens for advanced Hodgkin’s found the less intensive treatment was more effective for the blood cancer and caused fewer side effects.
    • Dr. Tatjana Kolevska, medical director for the Kaiser Permanente National Cancer Excellence Program, who was not involved in the new research: “Do we need all that treatment that we have used in the past?”
  • Bias (100%)
    None Found At Time Of Publication
  • Site Conflicts Of Interest (100%)
    None Found At Time Of Publication
  • Author Conflicts Of Interest (0%)
    None Found At Time Of Publication